U.S. Food and Drug Administration, Center for Drug Evaluation and Research
20 episodes
9 months ago
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
All content for Q&A with FDA is the property of U.S. Food and Drug Administration, Center for Drug Evaluation and Research and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
Q&A with FDA
14 minutes
11 months ago
Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
Q&A with FDA
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
